NDRA
Endra Life Sciences·NASDAQ
--
--(--)
--
--(--)
5.66 / 10
Netural
Sentiment is neutral (5.66) but fund‑flow scores 7.3, deemed good. Small‑cap inflows are positive while larger blocks are negative. Analyst consensus is a single Strong Buy, yet historical win rate is only 25%. bullish sentiment exists but confidence is limited.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionAscendiant Capital
Times predicted4
Historical Win Rate25.0%
Is money flowing into or out of NDRA?
- NDRA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.66/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
